AGP Executive Report
Last update: 2 hours agoInfant Formula Safety in Focus: Hong Kong parents are rushing babies for check-ups after a lead scare linked to Frisolac Prestige Stage 1 (batch 1W07KPJ), with the Centre for Food Safety requesting a recall and families questioning whether other products from the same brand are safe. Greater Bay Area Clinical Trials: A Hong Kong-based start-up, Health Hope Pharma, will run large-scale Greater Bay Area trials for metastatic breast cancer and macular degeneration, tapping Hong Kong plus Shenzhen’s patient pool. Cancer Drug Updates (HK-listed): Hansoh Pharma said its B7-H3 antibody-drug conjugate HS-20093 met a late-stage primary endpoint in China, while another Hansoh/GSK osteosarcoma programme Ris-Rez (Risvutatug rezetecan) also hit progression-free survival goals. Primary Care Expansion: Siu Sai Wan Family Medicine Clinic is set to start services on August 1, boosting primary healthcare in the Eastern District. Public Health Alerts: The Department of Health continues monitoring infants after powdered infant formula was found with lead possibly exceeding limits, urging vigilance. Tech-to-Health Innovation: An AI-driven EMG control framework is reported to improve robotic assistance for older adults, aiming to make real-world use more practical. Local Tragedy: A child died after a crash near Shercock in Ireland, with the driver also killed and investigators appealing for dash-cam footage.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
